Infectious Disease Special Edition: Investigational Drug TBD09 Holds Promise for TB

28 January 2026

Infectious Disease Special Edition news story

The investigational antibiotic TBD09 could have the potential to treat TB with less toxicity, according to new research.

The preclinical study, published in Nature Medicine, shows that TBD09, also called MK-7762, had strong efficacy in animal models with a favorable safety profile. These results, and favorable phase 1 data, indicate TBD09 may hold promise for TB.

TBD09 is an oxazolidinone, the same class as linezolid.

Read the full news story here.

Source: Infectious Disease Special Edition